Income Statement
INMUNE BIO, INC.
INMB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0.05 | 0.01 | 0.16 | 0.37 | 0.18 | 0.01 | - | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - |
|
Gross Profit
|
0.05 | 0.01 | 0.16 | 0.37 | 0.18 | 0.01 | - | - |
|
Operating Expenses
|
47.43 | 42.65 | 29.90 | 26.33 | 29.33 | 12.24 | 7.76 | 12.44 |
|
Research & Development
|
20.66 | 33.17 | 20.27 | 17.07 | 20.54 | 5.92 | 3.28 | 1.11 |
|
Selling, General & Administrative
|
10.26 | 9.48 | 9.62 | 9.26 | 8.79 | 6.32 | 6.02 | 11.33 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - |
|
Operating Income
|
-47.38 | -42.64 | -29.74 | -25.95 | -29.15 | -12.23 | -7.76 | -12.44 |
|
Non-Operating Income
|
1.45 | 0.55 | - | - | -1.19 | - | - | - |
|
Interest Income
|
- | - | - | - | - | - | 0.08 | - |
|
Interest Expense
|
0.00 | 0.79 | 2.28 | 2.01 | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | 0.55 | -0.27 | - | - | 0.13 | 0.08 | - |
|
Income Before Tax
|
45.93 | 42.08 | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - |
|
Net Income
|
-45.93 | -42.08 | -30.01 | -27.30 | -30.34 | 12.10 | 7.68 | -12.44 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
-47.38 | -42.64 | -29.74 | -25.95 | -29.15 | -12.23 | -7.76 | -12.44 |
|
Earnings Per Share (Basic)
|
-1.86 | -2.11 | -1.67 | -1.52 | - | - | - | - |
|
Diluted EPS
|
-1.86 | -2.11 | - | - | - | - | - | - |
|
Weighted Average Shares
|
24.76 | 19.94 | 17.98 | 17.93 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
24.76 | 19.94 | - | - | - | - | - | - |
|
Comprehensive Income
|
-46.10 | -41.86 | -30.11 | -28.00 | -30.35 | -12.08 | -7.69 | -12.47 |